azurite therapeutics private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 15 September 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 1 bids — DHARA DISTRIBUTORS SURGICAL AND PHARMACEUTICALS appeared in 1 of them.
AZURITE THERAPEUTICS PRIVATE LIMITED
AZURITE THERAPEUTICS PRIVATE LIMITED
Financial Details
Registered Office
S NO 63 H NO 59/12 WING E FL NO. 304 VIVA SAROVAR DATTANAGAR JAMBHULWADI ROADNA-PUNE-Maharashtra-411046-India
Industry Classification
Manufacturing (Metals & Chemicals, and products thereof)
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TendersAi transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
1
Contract Value
₹5.15 Lakh
L1 Bids
1
Recent Win Rate
100.0%
Performance Analytics
Azurite Therapeutics: Government Tender Performance Analysis
Executive Summary
Azurite Therapeutics Private Limited is an emerging player in the Indian government tender landscape. With participation in 1 tenders between FY2018-19 and FY2024-25, the company has demonstrated exceptional performance, achieving a 100.0% win rate. This translates to securing 1 L1 position (lowest bid winner), showcasing their competitiveness in government procurement. Their financial health assessment, according to TenderAI scoring, is satisfactory, with a score of 58.5/100. This is driven by a strong win rate score, but tempered by weaknesses in contract value and consistency. Azurite Therapeutics's primary engagement has been with the Ministry of Defence, indicating a specialized focus in this sector.
This analysis delves into Azurite Therapeutics' tender performance, providing insights into their financial metrics, product/service category performance, geographical distribution, competitive landscape, and a comprehensive SWOT analysis. We also offer strategic recommendations and a future growth outlook, tailored for government procurement officers, industry specialists, and potential investors.
Financial Performance Analysis
Yearly Trends
Azurite Therapeutics began participating in government tenders in FY2024-25, securing 1 win out of 1 bid. There is no prior year data for comparison. The total contract value secured in FY2024-25 is ₹5,14,988. The following table summarizes the yearly performance:
Fiscal Year | Bid Count | Win Count | Qualification Rate | Win Rate | Total Contract Value |
---|---|---|---|---|---|
FY 2018-19 | 0 | 0 | 0.0% | 0.0% | ₹0 |